Eikonoklastes completes a license to add novel gene therapy for treating neurodegener

[News]

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company, today announced it has completed a license with the University of California San Diego to add a novel gene therapy for the treatment of neurodegenerative diseases.

More... (https://www.news-medical.net/news/20220120/Eikonoklastes-completes-a-license-to-add-novel-gene-therapy-for-treating-neurodegenerative-diseases.aspx)